Viral T-antigen interactions with cellular proto-oncogene and anti-oncogene products.
Schreier
A A
AA
Biological Carcinogenesis Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Gruber
J
J
D019870:1-Phosphatidylinositol 4-Kinase; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000378:metabolism*; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism; D015688:Oncogene Protein pp60(v-src) / Q000378:metabolism; D015513:Oncogene Proteins / Q000378:metabolism*; D009856:Oncogene Proteins, Viral / Q000378:metabolism; D010750:Phosphoproteins / Q000378:metabolism; D010770:Phosphotransferases / Q000378:metabolism; D011485:Protein Binding; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53
D000952:Antigens, Polyomavirus Transforming; C000715470:MAS1 protein, human; D009363:Neoplasm Proteins; D015513:Oncogene Proteins; D009856:Oncogene Proteins, Viral; D010750:Phosphoproteins; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53; D010770:Phosphotransferases; D019870:1-Phosphatidylinositol 4-Kinase; D015688:Oncogene Protein pp60(v-src)